The explosion of Alejandro Balde like defender of the first team of the FC Barcelona has been notorious during this season. The club looked for him an exit during the summer happened to free his index card but Xavi Hernández bet by him after evaluating him in the pre-season by the United States. So only a day sufficed him to the defender to do with a place inside the eleven initial, leaving in the dry dam to Jordi Alba and Marcos Alonso.

Balde Has been crucial for Xavi

In fact, the big feelings that left during the first stretch of the course cost him to go in inside the announcement of Luis Enrique for the World-wide of Qatar, and nowadays accumulates a total of 41 parties in all the competitions. His only so much occurred the past Sunday in front of the RCD Espanyol and has delivered seven assistances to his mates in 2.913' minutes played.

Now, with all this on the table, an information of the newspaper 'SPORT' ensures that his renewal with the Barça already is pactada and will continue inside the discipline culé until the 2027. The contacts between the sportive direction and his agent, Jorge Mendes, have directed from finals of 2022 and everything would be for arriving to good port with an agreement that will improve to a large extent his emolumentos and will have a clause of rescission of 1.000 million euros.

The Barça expects the approval of LaLiga

It is important to remember that Balde has contested all the season with index card and dorsal of the filial, by what the club is by the work to improve all his income for being an indisputable inside the alignments of the trainer. Now well, the agreement will consolidate once the Barcelona receive the seen well of LaLiga to the plan of feasibility presented does some weeks.

The commission delegated of the patronal will gather this Friday and expects that they give green light to the planning of the entity, that no only will contemplate the renewal of the canterano but also the registrations of the new agreement of Ronald Araújo, Sergi Roberto, Marcos Alonso, and Gavi.